Concepts (220)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Parvalbumins | 12 | 2023 | 261 | 1.480 |
Why?
|
| Wakefulness | 14 | 2024 | 1265 | 1.090 |
Why?
|
| Prosencephalon | 6 | 2016 | 305 | 1.000 |
Why?
|
| Rodentia | 2 | 2020 | 262 | 0.720 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 2 | 2020 | 1081 | 0.680 |
Why?
|
| Arousal | 5 | 2022 | 1166 | 0.630 |
Why?
|
| Sleep | 13 | 2024 | 4768 | 0.630 |
Why?
|
| Neurons | 13 | 2023 | 9463 | 0.600 |
Why?
|
| Carbohydrates | 1 | 2020 | 390 | 0.600 |
Why?
|
| Sleep Deprivation | 8 | 2023 | 846 | 0.590 |
Why?
|
| Acoustic Stimulation | 2 | 2020 | 1235 | 0.540 |
Why?
|
| Pharmaceutical Preparations | 1 | 2020 | 1089 | 0.390 |
Why?
|
| Indenes | 1 | 2012 | 59 | 0.380 |
Why?
|
| Theta Rhythm | 1 | 2013 | 220 | 0.370 |
Why?
|
| Sleep, REM | 6 | 2019 | 595 | 0.370 |
Why?
|
| Rats | 21 | 2021 | 23741 | 0.360 |
Why?
|
| Choline O-Acetyltransferase | 2 | 2014 | 156 | 0.350 |
Why?
|
| Cholinergic Agents | 2 | 2021 | 96 | 0.320 |
Why?
|
| Raphe Nuclei | 3 | 2006 | 103 | 0.310 |
Why?
|
| Sleep Stages | 4 | 2016 | 694 | 0.310 |
Why?
|
| Rats, Sprague-Dawley | 13 | 2018 | 8181 | 0.300 |
Why?
|
| Disorders of Excessive Somnolence | 2 | 2008 | 277 | 0.300 |
Why?
|
| Polysomnography | 4 | 2009 | 1848 | 0.300 |
Why?
|
| Glutamate Decarboxylase | 4 | 2014 | 239 | 0.280 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 2009 | 586 | 0.270 |
Why?
|
| Receptors, Neuropeptide | 3 | 2013 | 106 | 0.270 |
Why?
|
| Motor Cortex | 2 | 2013 | 1007 | 0.260 |
Why?
|
| Locus Coeruleus | 2 | 2022 | 230 | 0.250 |
Why?
|
| Attention | 6 | 2023 | 2396 | 0.250 |
Why?
|
| Animals | 42 | 2024 | 168475 | 0.250 |
Why?
|
| Midline Thalamic Nuclei | 1 | 2004 | 14 | 0.250 |
Why?
|
| Triazoles | 2 | 2021 | 903 | 0.240 |
Why?
|
| Adenosine | 5 | 2018 | 808 | 0.240 |
Why?
|
| Neuronal Plasticity | 1 | 2013 | 1436 | 0.240 |
Why?
|
| Vesicular Glutamate Transport Protein 2 | 2 | 2021 | 53 | 0.230 |
Why?
|
| Electroencephalography | 14 | 2020 | 6237 | 0.220 |
Why?
|
| Cell Membrane | 1 | 2013 | 3687 | 0.220 |
Why?
|
| Brain Chemistry | 1 | 2007 | 960 | 0.220 |
Why?
|
| Transcranial Magnetic Stimulation | 1 | 2013 | 1473 | 0.210 |
Why?
|
| Piperidines | 3 | 2021 | 1656 | 0.210 |
Why?
|
| Hippocampus | 5 | 2006 | 3766 | 0.210 |
Why?
|
| Sleep Apnea, Obstructive | 2 | 2013 | 1875 | 0.200 |
Why?
|
| Septum of Brain | 1 | 2000 | 18 | 0.190 |
Why?
|
| gamma-Aminobutyric Acid | 5 | 2022 | 1141 | 0.180 |
Why?
|
| Septal Nuclei | 1 | 2001 | 85 | 0.180 |
Why?
|
| Animal Feed | 1 | 2020 | 112 | 0.170 |
Why?
|
| Mice | 20 | 2023 | 81539 | 0.170 |
Why?
|
| Pons | 1 | 2001 | 240 | 0.170 |
Why?
|
| Avoidance Learning | 1 | 2021 | 248 | 0.170 |
Why?
|
| Receptors, G-Protein-Coupled | 3 | 2013 | 1252 | 0.160 |
Why?
|
| Maze Learning | 3 | 2012 | 483 | 0.160 |
Why?
|
| Nitric Oxide Synthase Type I | 1 | 2019 | 174 | 0.160 |
Why?
|
| Delta Rhythm | 1 | 2019 | 81 | 0.160 |
Why?
|
| Thalamic Nuclei | 1 | 2019 | 111 | 0.160 |
Why?
|
| Antipsychotic Agents | 1 | 2012 | 3067 | 0.150 |
Why?
|
| Microdialysis | 5 | 2016 | 161 | 0.150 |
Why?
|
| Evoked Potentials, Auditory | 2 | 2019 | 530 | 0.150 |
Why?
|
| Glutamic Acid | 2 | 2021 | 1176 | 0.150 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2024 | 1136 | 0.150 |
Why?
|
| Motor Activity | 2 | 2010 | 2715 | 0.150 |
Why?
|
| Somatostatin | 1 | 2019 | 447 | 0.140 |
Why?
|
| Mice, Transgenic | 6 | 2024 | 9542 | 0.140 |
Why?
|
| Receptors, Purinergic P2 | 1 | 2018 | 150 | 0.140 |
Why?
|
| Gene Knock-In Techniques | 3 | 2013 | 421 | 0.140 |
Why?
|
| Brain Waves | 2 | 2019 | 409 | 0.140 |
Why?
|
| Glutamates | 1 | 2017 | 389 | 0.130 |
Why?
|
| Action Potentials | 3 | 2017 | 1834 | 0.120 |
Why?
|
| Neural Pathways | 3 | 2012 | 3060 | 0.120 |
Why?
|
| Schizophrenia | 3 | 2020 | 6937 | 0.120 |
Why?
|
| Auditory Perception | 1 | 2019 | 583 | 0.110 |
Why?
|
| Excitatory Amino Acid Antagonists | 2 | 2018 | 448 | 0.110 |
Why?
|
| Parasympathetic Nervous System | 1 | 2014 | 142 | 0.110 |
Why?
|
| Patch-Clamp Techniques | 4 | 2018 | 927 | 0.110 |
Why?
|
| Tegmentum Mesencephali | 1 | 2013 | 59 | 0.100 |
Why?
|
| Disease Models, Animal | 7 | 2012 | 18255 | 0.100 |
Why?
|
| Electromyography | 4 | 2016 | 1394 | 0.100 |
Why?
|
| Green Fluorescent Proteins | 4 | 2014 | 2065 | 0.100 |
Why?
|
| Memory | 2 | 2019 | 2193 | 0.100 |
Why?
|
| Psychomotor Performance | 3 | 2008 | 1882 | 0.100 |
Why?
|
| Cell Count | 2 | 2009 | 1835 | 0.100 |
Why?
|
| Serotonin | 2 | 2006 | 1041 | 0.090 |
Why?
|
| Male | 27 | 2024 | 360846 | 0.090 |
Why?
|
| Cerebral Cortex | 2 | 2019 | 5779 | 0.090 |
Why?
|
| Darkness | 1 | 2010 | 158 | 0.090 |
Why?
|
| Alzheimer Disease | 1 | 2012 | 8601 | 0.090 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 2012 | 426 | 0.090 |
Why?
|
| CA1 Region, Hippocampal | 1 | 2009 | 110 | 0.080 |
Why?
|
| Brain | 3 | 2012 | 27121 | 0.080 |
Why?
|
| Reticular Formation | 1 | 2008 | 59 | 0.070 |
Why?
|
| Rats, Inbred F344 | 4 | 2010 | 826 | 0.070 |
Why?
|
| Presenilin-1 | 1 | 2012 | 660 | 0.070 |
Why?
|
| Prefrontal Cortex | 2 | 2011 | 2220 | 0.070 |
Why?
|
| Physical Stimulation | 1 | 2009 | 517 | 0.070 |
Why?
|
| Neuropeptides | 3 | 2010 | 944 | 0.070 |
Why?
|
| Plaque, Amyloid | 1 | 2012 | 760 | 0.070 |
Why?
|
| Acetylcholine | 2 | 2022 | 629 | 0.070 |
Why?
|
| Pyramidal Cells | 1 | 2009 | 369 | 0.070 |
Why?
|
| Reaction Time | 4 | 2023 | 2089 | 0.070 |
Why?
|
| Cognition Disorders | 2 | 2012 | 3980 | 0.070 |
Why?
|
| Narcolepsy | 1 | 2009 | 199 | 0.070 |
Why?
|
| Amyloid beta-Protein Precursor | 1 | 2012 | 1111 | 0.070 |
Why?
|
| Dimethylphenylpiperazinium Iodide | 1 | 2005 | 6 | 0.070 |
Why?
|
| Spatial Behavior | 1 | 2006 | 88 | 0.070 |
Why?
|
| Space Perception | 1 | 2009 | 465 | 0.070 |
Why?
|
| Gene Knockdown Techniques | 1 | 2010 | 1612 | 0.060 |
Why?
|
| Time Factors | 5 | 2012 | 39969 | 0.060 |
Why?
|
| Ketamine | 1 | 2011 | 519 | 0.060 |
Why?
|
| Carbachol | 2 | 2017 | 223 | 0.060 |
Why?
|
| Eye Movements | 1 | 2008 | 511 | 0.060 |
Why?
|
| Discrimination Learning | 1 | 2007 | 278 | 0.060 |
Why?
|
| Long-Term Potentiation | 1 | 2006 | 293 | 0.060 |
Why?
|
| Afferent Pathways | 1 | 2004 | 298 | 0.060 |
Why?
|
| Up-Regulation | 2 | 2009 | 4125 | 0.050 |
Why?
|
| Nicotinic Agonists | 1 | 2005 | 265 | 0.050 |
Why?
|
| Receptors, GABA-A | 2 | 2022 | 623 | 0.050 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 3 | 2010 | 2872 | 0.050 |
Why?
|
| Luminescent Proteins | 2 | 2017 | 837 | 0.050 |
Why?
|
| Behavior, Animal | 2 | 2010 | 1878 | 0.050 |
Why?
|
| Nucleus Accumbens | 1 | 2005 | 366 | 0.050 |
Why?
|
| Immunohistochemistry | 3 | 2014 | 11076 | 0.050 |
Why?
|
| Memory Disorders | 1 | 2009 | 1199 | 0.050 |
Why?
|
| Diet | 1 | 2020 | 8075 | 0.050 |
Why?
|
| Analysis of Variance | 2 | 2007 | 6228 | 0.050 |
Why?
|
| Executive Function | 1 | 2010 | 1392 | 0.050 |
Why?
|
| Animals, Genetically Modified | 2 | 2017 | 1561 | 0.040 |
Why?
|
| Axonal Transport | 1 | 2001 | 178 | 0.040 |
Why?
|
| Nicotine | 1 | 2005 | 680 | 0.040 |
Why?
|
| Dentate Gyrus | 1 | 2001 | 164 | 0.040 |
Why?
|
| Norepinephrine | 1 | 2022 | 897 | 0.040 |
Why?
|
| Exercise Test | 1 | 2007 | 2127 | 0.040 |
Why?
|
| Mesencephalon | 1 | 2001 | 332 | 0.040 |
Why?
|
| Purinergic P2 Receptor Agonists | 1 | 2018 | 13 | 0.040 |
Why?
|
| Homeostasis | 1 | 2010 | 3323 | 0.040 |
Why?
|
| Membrane Potentials | 2 | 2014 | 1090 | 0.040 |
Why?
|
| Amyloid beta-Peptides | 1 | 2012 | 3839 | 0.040 |
Why?
|
| Purinergic P2 Receptor Antagonists | 1 | 2018 | 67 | 0.040 |
Why?
|
| Amygdala | 1 | 2006 | 1354 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 3 | 2023 | 22174 | 0.040 |
Why?
|
| Appetitive Behavior | 2 | 2008 | 39 | 0.040 |
Why?
|
| Receptors, Glutamate | 1 | 2018 | 228 | 0.040 |
Why?
|
| Electrophysiological Phenomena | 1 | 2019 | 307 | 0.030 |
Why?
|
| Sodium Channel Blockers | 1 | 2017 | 173 | 0.030 |
Why?
|
| Tetrodotoxin | 1 | 2017 | 246 | 0.030 |
Why?
|
| Biological Assay | 1 | 2019 | 626 | 0.030 |
Why?
|
| Apoptosis | 1 | 2012 | 9490 | 0.030 |
Why?
|
| Thalamus | 1 | 2022 | 1047 | 0.030 |
Why?
|
| Circadian Rhythm | 1 | 2007 | 2576 | 0.030 |
Why?
|
| Cholinergic Antagonists | 1 | 2016 | 168 | 0.030 |
Why?
|
| Muscarinic Agonists | 1 | 2014 | 91 | 0.030 |
Why?
|
| Calcium Channel Blockers | 1 | 2017 | 694 | 0.030 |
Why?
|
| Electrodes, Implanted | 1 | 2018 | 840 | 0.030 |
Why?
|
| Receptors, Muscarinic | 1 | 2014 | 157 | 0.030 |
Why?
|
| Fluorescent Dyes | 1 | 2001 | 1903 | 0.030 |
Why?
|
| RNA, Small Interfering | 2 | 2013 | 3430 | 0.030 |
Why?
|
| Lysine | 1 | 2017 | 993 | 0.030 |
Why?
|
| Photoperiod | 1 | 2013 | 139 | 0.020 |
Why?
|
| Adenosine Triphosphate | 1 | 2018 | 1989 | 0.020 |
Why?
|
| Transduction, Genetic | 1 | 2015 | 903 | 0.020 |
Why?
|
| Electric Stimulation | 1 | 2017 | 1736 | 0.020 |
Why?
|
| Models, Animal | 1 | 2018 | 2112 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 2017 | 2677 | 0.020 |
Why?
|
| Benzamides | 1 | 2017 | 1371 | 0.020 |
Why?
|
| Hypnotics and Sedatives | 1 | 2019 | 1179 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2012 | 39106 | 0.020 |
Why?
|
| Receptor, Adenosine A1 | 1 | 2009 | 42 | 0.020 |
Why?
|
| Synaptic Membranes | 1 | 2009 | 89 | 0.020 |
Why?
|
| Microinjections | 1 | 2010 | 321 | 0.020 |
Why?
|
| Mice, Knockout | 2 | 2019 | 14417 | 0.020 |
Why?
|
| Rats, Transgenic | 1 | 2009 | 69 | 0.020 |
Why?
|
| Data Collection | 1 | 2019 | 3322 | 0.020 |
Why?
|
| Photic Stimulation | 1 | 2016 | 1987 | 0.020 |
Why?
|
| Organ Culture Techniques | 1 | 2011 | 795 | 0.020 |
Why?
|
| Ion Channels | 1 | 2014 | 1040 | 0.020 |
Why?
|
| Dog Diseases | 1 | 2009 | 141 | 0.020 |
Why?
|
| Humans | 8 | 2020 | 761596 | 0.020 |
Why?
|
| Theophylline | 1 | 2008 | 131 | 0.020 |
Why?
|
| Mutation | 1 | 2012 | 30053 | 0.020 |
Why?
|
| Rats, Inbred BN | 1 | 2007 | 231 | 0.020 |
Why?
|
| Interneurons | 1 | 2011 | 593 | 0.020 |
Why?
|
| Reversal Learning | 1 | 2007 | 57 | 0.020 |
Why?
|
| Gene Silencing | 1 | 2013 | 1509 | 0.020 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2011 | 895 | 0.020 |
Why?
|
| Receptors, Presynaptic | 1 | 2005 | 15 | 0.020 |
Why?
|
| Locomotion | 1 | 2008 | 388 | 0.020 |
Why?
|
| 8-Hydroxy-2-(di-n-propylamino)tetralin | 1 | 2005 | 32 | 0.020 |
Why?
|
| Color Perception | 1 | 2007 | 213 | 0.020 |
Why?
|
| Nicotinic Antagonists | 1 | 2005 | 94 | 0.020 |
Why?
|
| Random Allocation | 1 | 2010 | 2395 | 0.020 |
Why?
|
| Neurotransmitter Agents | 1 | 2009 | 665 | 0.020 |
Why?
|
| Corticosterone | 1 | 2006 | 305 | 0.020 |
Why?
|
| Pyrimidines | 1 | 2017 | 3028 | 0.010 |
Why?
|
| Serotonin Receptor Agonists | 1 | 2005 | 151 | 0.010 |
Why?
|
| Mice, Mutant Strains | 1 | 2008 | 1749 | 0.010 |
Why?
|
| Smell | 1 | 2007 | 259 | 0.010 |
Why?
|
| Female | 5 | 2019 | 392705 | 0.010 |
Why?
|
| Dogs | 1 | 2009 | 3839 | 0.010 |
Why?
|
| Cognition | 2 | 2012 | 6992 | 0.010 |
Why?
|
| Memory, Short-Term | 1 | 2010 | 982 | 0.010 |
Why?
|
| Citalopram | 1 | 2005 | 402 | 0.010 |
Why?
|
| Receptors, Nicotinic | 1 | 2005 | 495 | 0.010 |
Why?
|
| Sleep Apnea Syndromes | 1 | 2010 | 975 | 0.010 |
Why?
|
| Bacterial Proteins | 1 | 2015 | 3847 | 0.010 |
Why?
|
| Learning | 1 | 2010 | 1740 | 0.010 |
Why?
|
| Emotions | 1 | 2012 | 2739 | 0.010 |
Why?
|
| Nerve Tissue Proteins | 1 | 2012 | 4415 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2013 | 7593 | 0.010 |
Why?
|
| Proteomics | 1 | 2012 | 3848 | 0.010 |
Why?
|
| Algorithms | 1 | 2019 | 14033 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2013 | 12794 | 0.010 |
Why?
|
| Oxygen | 1 | 2009 | 4227 | 0.010 |
Why?
|
| Motivation | 1 | 2007 | 2006 | 0.010 |
Why?
|
| Neuropsychological Tests | 1 | 2010 | 7054 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2015 | 20100 | 0.010 |
Why?
|
| Genomics | 1 | 2012 | 5821 | 0.010 |
Why?
|
| Phenotype | 1 | 2012 | 16592 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2006 | 10766 | 0.010 |
Why?
|
| Carrier Proteins | 1 | 2005 | 4937 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2008 | 15843 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2012 | 17904 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2012 | 23447 | 0.010 |
Why?
|
Concepts
(220)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(19)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_